The Bull

Thursday 16

August, 2018 8:21 PM



Executive Series 24 Apr 18: Elixinol Global (EXL) CEO, Paul Benhaim

Executive Series 24 Apr 18: Elixinol Global (EXL) CEO, Paul Benhaim

Executive Series 24 Apr 18: Elixinol Global (EXL) CEO, Paul Benhaim.

Share |

30.04.2018 02:05 PM

In this short video we discuss:

• Elixinol’s (EXL) three key business units, including the established U.S. operations, where it manufactures and distributes industrial hemp-based nutraceuticals, dietary supplements and skincare products

• EXL’s domestic operations, which were founded in 1999 and manufactures and distributes industrial hemp-derived products in Australia.

• The importance and direction of legislative changes in the medicinal cannabis market and EXL’s strategy to leverage a range of emerging cannabis related sectors including hemp, Cannabidiol (CBD) nutraceuticals and wellness products

Click here to view video
To view more Executive Series interviews, visit:
Archive
Markets
Index: Points Change Percent

PLEASE SUPPORT OUR SPONSORS, AUSTRALIA'S LEADING BROKERS:



© Copyright TheBull.com.au. All rights reserved.